Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592316 · ClinicalTrials.gov registry record · NA
Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients
A NA study of Lower Extremity Amputation, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT03592316: Completed NA study of Lower Extremity Amputation, sponsored by University of California, San Francisco.
NCT03592316 is a NA study of Lower Extremity Amputation that has completed, run by University of California, San Francisco. The registered enrollment target is 11 participants, below the 19-participant average among 3 other Lower Extremity Amputation trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592316, a NA study of Lower Extremity Amputation, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral amputations. A consecutive sample of patients diagnosed with peripheral vascular disease and/or diabetes requiring major lower extremity amputation will be enrolled in the study and compared to retrospective controls.
Primary Outcome
The total hospital length of stay for the lower extremity amputation admission
Conditions Studied
Interventions
- OTHER Lower Extremity Amputation Pathway
Study Locations (1)
California
- Community Regional Medical Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-11-14 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT03592316 record still lists
NCT03592316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 19-participant average among 3 other Lower Extremity Amputation trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Lower Extremity Amputation appearing as the primary indexed condition, and to 1 intervention - of which Lower Extremity Amputation Pathway is the first listed.
NCT03592316 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03592316 about?
NCT03592316 is a clinical study titled "Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients". The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral...
What is the current status of trial NCT03592316?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-11-14. Estimated completion is 2020-12-31.
What conditions does trial NCT03592316 study?
This clinical trial studies the following conditions: Lower Extremity Amputation.
What interventions are being tested in trial NCT03592316?
The interventions under investigation include: Lower Extremity Amputation Pathway (OTHER).
Who is sponsoring clinical trial NCT03592316?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03592316 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Extremity Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Prosthetic Provision in Rural Communities: Limb Scanning With Caregiver Assistance
RECRUITING · NA
-
Pivot-Flex Foot: Optimal Coupling Ratio Between Transverse and Sagittal-plane Motions Using a Torsionally Adaptive Prosthesis for Individuals With Lower Limb Amputation
COMPLETED · NA
-
Pilot Study to Assess the Use of Spy Elite for Assessment of Amputation Healing
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI